The bipartisan 21st Century Cures Act, headed to the Senate after passage in the House by a huge margin—392 to 26—is meeting with mixed reactions by many.
Some of its best features are money to fight the opioid epidemic, funding for National Institutes of Health projects—the cancer “moonshot,” the BRAIN Initiative and the Precision Medicine Initiative—and support for mental health.
|Benefits to the pharmaceutical industry
But Business Insider reported that on the flip side are features that spurred former supporters of the bill Senators Elizabeth Warren, D-Massachusetts, and Bernie Sanders, I-Vermont, to withdraw their backing, with both declaring it a giveaway to the pharmaceutical industry.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
